These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31835039)

  • 1. ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial.
    Ueland T; Åkerblom A; Ghukasyan T; Michelsen AE; Becker RC; Bertilsson M; Budaj A; Cornel JH; Himmelmann A; James SK; Siegbahn A; Storey RF; Kontny F; Aukrust P; Wallentin L;
    Atherosclerosis; 2020 Jan; 293():35-41. PubMed ID: 31835039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
    Ueland T; Åkerblom A; Ghukasyan T; Michelsen AE; Aukrust P; Becker RC; Bertilsson M; Himmelmann A; James SK; Siegbahn A; Storey RF; Kontny F; Wallentin L;
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29330256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study.
    Hagström E; James SK; Bertilsson M; Becker RC; Himmelmann A; Husted S; Katus HA; Steg PG; Storey RF; Siegbahn A; Wallentin L;
    Eur Heart J; 2016 Apr; 37(16):1325-33. PubMed ID: 26417057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated leukocyte cell adhesion molecule and prognosis in acute ischemic stroke.
    Smedbakken L; Jensen JK; Hallén J; Atar D; Januzzi JL; Halvorsen B; Aukrust P; Ueland T
    Stroke; 2011 Sep; 42(9):2453-8. PubMed ID: 21757661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: A substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial.
    Kontny F; Andersen T; Ueland T; Åkerblom A; Lakic TG; Michelsen AE; Aukrust P; Bertilsson M; Becker RC; Himmelmann A; James SK; Siegbahn A; Storey RF; Wallentin L;
    Eur Heart J Acute Cardiovasc Care; 2020 Jun; 9(4):313-322. PubMed ID: 31017470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.
    Sumaya W; Wallentin L; James SK; Siegbahn A; Gabrysch K; Bertilsson M; Himmelmann A; Ajjan RA; Storey RF
    Eur Heart J; 2018 Apr; 39(13):1078-1085. PubMed ID: 29390064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes.
    Andersen T; Ueland T; Ghukasyan Lakic T; Åkerblom A; Bertilsson M; Aukrust P; Michelsen AE; James SK; Becker RC; Storey RF; Wallentin L; Siegbahn A; Kontny F
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2402-2410. PubMed ID: 31554419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes.
    Ueland T; Åkerblom A; Ghukasyan T; Michelsen AE; Becker RC; Bertilsson M; Himmelmann A; James SK; Siegbahn A; Storey RF; Kontny F; Aukrust P; Wallentin L;
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):294-302. PubMed ID: 30580572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
    Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
    JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.
    Abraityte A; Aukrust P; Kou L; Anand IS; Young J; Mcmurray JJV; van Veldhuisen DJ; Gullestad L; Ueland T
    Clin Res Cardiol; 2019 Feb; 108(2):133-141. PubMed ID: 30051179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-18 in patients with acute coronary syndromes.
    Åkerblom A; James SK; Lakic TG; Becker RC; Cannon CP; Steg PG; Himmelmann A; Katus HA; Storey RF; Wallentin L; Weaver WD; Siegbahn A;
    Clin Cardiol; 2019 Dec; 42(12):1202-1209. PubMed ID: 31596518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
    Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
    J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial.
    Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK;
    Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study.
    Sumaya W; Wallentin L; James SK; Siegbahn A; Gabrysch K; Himmelmann A; Ajjan RA; Storey RF
    Thromb Haemost; 2020 Mar; 120(3):412-422. PubMed ID: 31975352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after planned invasive or conservative treatment strategy in patients with non-ST-elevation acute coronary syndrome and a normal value of high sensitivity troponin at randomisation: A Platelet Inhibition and Patient Outcomes (PLATO) trial biomarker substudy.
    Giannitsis E; Wallentin L; James SK; Bertilsson M; Siegbahn A; Storey RF; Husted S; Cannon CP; Armstrong PW; Steg PG; Katus HA;
    Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):500-510. PubMed ID: 27044282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
    Ihnen M; Kress K; Kersten JF; Kilic E; Choschzick M; Zander H; Müller V; Mahner S; Jänicke F; Woelber L; Milde-Langosch K
    BMC Cancer; 2012 Apr; 12():140. PubMed ID: 22475274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial.
    Mahaffey KW; Held C; Wojdyla DM; James SK; Katus HA; Husted S; Steg PG; Cannon CP; Becker RC; Storey RF; Khurmi NS; Nicolau JC; Yu CM; Ardissino D; Budaj A; Morais J; Montgomery D; Himmelmann A; Harrington RA; Wallentin L;
    J Am Coll Cardiol; 2014 Apr; 63(15):1493-9. PubMed ID: 24561148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.